BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 1584739)

  • 21. Comparative infectivity of oocysts and bradyzoites of Toxoplasma gondii for intermediate (mice) and definitive (cats) hosts.
    Dubey JP
    Vet Parasitol; 2006 Aug; 140(1-2):69-75. PubMed ID: 16647212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of compounds that suppress Toxoplasma gondii tachyzoites and bradyzoites.
    Murata Y; Sugi T; Weiss LM; Kato K
    PLoS One; 2017; 12(6):e0178203. PubMed ID: 28609444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The development and biology of bradyzoites of Toxoplasma gondii.
    Weiss LM; Kim K
    Front Biosci; 2000 Apr; 5():D391-405. PubMed ID: 10762601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of oral infectivity of tissue cysts of Toxoplasma gondii RH strain to outbred Swiss Webster mice.
    Villard O; Candolfi E; Ferguson DJ; Marcellin L; Kien T
    Int J Parasitol; 1997 Dec; 27(12):1555-9. PubMed ID: 9467741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An immunohistochemical method for detecting bradyzoite antigen (BAG5) in Toxoplasma gondii-infected tissues cross-reacts with a Neospora caninum bradyzoite antigen.
    McAllister MM; Parmley SF; Weiss LM; Welch VJ; McGuire AM
    J Parasitol; 1996 Apr; 82(2):354-5. PubMed ID: 8604117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oocyst shedding by cats fed isolated bradyzoites and comparison of infectivity of bradyzoites of the VEG strain Toxoplasma gondii to cats and mice.
    Dubey JP
    J Parasitol; 2001 Feb; 87(1):215-9. PubMed ID: 11227895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and co-localization of perforin-like (TgPLP1) protein in Toxoplasma gondii bradyzoites.
    Shan D; Qian W; Liu J; Liu R; Liu Q
    Exp Parasitol; 2015 Jun; 153():39-44. PubMed ID: 25746893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Starch Branching Enzyme 1 Is Important for Amylopectin Synthesis and Cyst Reactivation in Toxoplasma gondii.
    Yang J; He Z; Chen C; Zhao J; Fang R
    Microbiol Spectr; 2022 Jun; 10(3):e0189121. PubMed ID: 35446124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The organization of the wall filaments and characterization of the matrix structures of Toxoplasma gondii cyst form.
    Lemgruber L; Lupetti P; Martins-Duarte ES; De Souza W; Vommaro RC
    Cell Microbiol; 2011 Dec; 13(12):1920-32. PubMed ID: 21899696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toxoplasma gondii bradyzoites form spontaneously during sporozoite-initiated development.
    Jerome ME; Radke JR; Bohne W; Roos DS; White MW
    Infect Immun; 1998 Oct; 66(10):4838-44. PubMed ID: 9746587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The timing of sulfadiazine therapy impacts the reactivation of latent Toxoplasma infection in IRF-8-/- mice.
    Jost C; Reiter-Owona I; Liesenfeld O
    Parasitol Res; 2007 Nov; 101(6):1603-9. PubMed ID: 17846793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toxoplasma gondii: appearance of specific markers during the development of tissue cysts in vitro.
    Lane A; Soete M; Dubremetz JF; Smith JE
    Parasitol Res; 1996; 82(4):340-6. PubMed ID: 8740550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of molecular and ultrastructural markers to evaluate stage conversion of Toxoplasma gondii in both the intermediate and definitive host.
    Ferguson DJ
    Int J Parasitol; 2004 Mar; 34(3):347-60. PubMed ID: 15003495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunization of cats with tissue cysts, bradyzoites, and tachyzoites of the T-263 strain of Toxoplasma gondii.
    Freyre A; Choromanski L; Fishback JL; Popiel I
    J Parasitol; 1993 Oct; 79(5):716-9. PubMed ID: 8410543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Re-examination of resistance of Toxoplasma gondii tachyzoites and bradyzoites to pepsin and trypsin digestion.
    Dubey JP
    Parasitology; 1998 Jan; 116 ( Pt 1)():43-50. PubMed ID: 9481773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decoquinate induces tissue cyst formation by the RH strain of Toxoplasma gondii.
    Lindsay DS; Toivio-Kinnucan MA; Blagburn BL
    Vet Parasitol; 1998 Jun; 77(2-3):75-81. PubMed ID: 9746277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanosilver Colloid Inhibits
    Shojaee S; Firouzeh N; Keshavarz H; Jafar-Pour Azami S; Salimi M; Mohebali M
    Iran J Parasitol; 2019; 14(3):362-367. PubMed ID: 31673253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toxoplasma gondii actively inhibits neuronal function in chronically infected mice.
    Haroon F; Händel U; Angenstein F; Goldschmidt J; Kreutzmann P; Lison H; Fischer KD; Scheich H; Wetzel W; Schlüter D; Budinger E
    PLoS One; 2012; 7(4):e35516. PubMed ID: 22530040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spontaneous cystogenesis in vitro of a Brazilian strain of Toxoplasma gondii.
    Paredes-Santos TC; Martins-Duarte ES; Vitor RW; de Souza W; Attias M; Vommaro RC
    Parasitol Int; 2013 Apr; 62(2):181-8. PubMed ID: 23269201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural changes of Toxoplasma gondii bradyzoites and cysts following therapy with sulfamethoxypyrazine-pyrimethamine: studies by light and electron microscopy. Consequences for chemotherapy.
    Werner H; Matuschka FR; Brandenburg I
    Zentralbl Bakteriol Orig A; 1979 Oct; 245(1-2):240-53. PubMed ID: 44617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.